Skip to main content

Mira Moufarrej developed three liquid biopsy tests that measure cell-free RNA to predict how far along a pregnancy is and whether a mother is at risk of preeclampsia and preterm delivery, with results available earlier than with traditional diagnostics. This work paves the way for affordable, simple, and reliable tests for preeclampsia and preterm delivery risk administered early enough for meaningful clinical intervention. For this work, Mira received the 2021 “Cure it!” Lemelson-MIT Student Prize and recognized as a top 10 innovation of 2019 in the MIT Technology Review.

Leave a Reply